IVERIC bio, Inc. (ISEE): Price and Financial Metrics
ISEE Price/Volume Stats
| Current price | $39.95 | 52-week high | $39.99 |
| Prev. close | $39.80 | 52-week low | $9.39 |
| Day low | $39.85 | Volume | 10,999,100 |
| Day high | $39.99 | Avg. volume | 3,616,141 |
| 50-day MA | $38.02 | Dividend yield | N/A |
| 200-day MA | $26.09 | Market Cap | 5.50B |
ISEE Stock Price Chart Interactive Chart >
IVERIC bio, Inc. (ISEE) Company Bio
IVERIC bio, Inc. (formerly Ophthotech Corporation) is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). The company was founded in 2007 and is based in New York, New York.
Latest ISEE News From Around the Web
Below are the latest news stories about IVERIC BIO INC that investors may wish to consider to help them evaluate ISEE as an investment opportunity.
Astellas Completes Acquisition of Iveric BioAstellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has successfully completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE, CEO: Glenn P. Sblendorio, "Iveric Bio") with respect to the announcement on April 30, 2023, through its indirect wholly-owned subsidiary Berry Merger Sub, Inc. (the "Acquisition"). The Acquisition was completed on July 11, 2023, US Eastern Time, as follows, and Iveric Bio has become Astellas' wholly-owned subsidiary. |
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PARSIPPANY, N.J., July 05, 2023--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 23 newly-hired, non-executive employees. |
Annexon (ANNX) Stock Down More Than 50% Last Week: Here's WhyAnnexon (ANNX) announces mixed top-line results from the phase II study of ANX007 in patients with geographic atrophy. |
Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas PharmaAstellas Pharma snapped up Iveric Bio for $5.9 billion in cash, the companies said Monday in an announcement that sent ISEE stock flying. |
These Stocks Moved the Most Today: First Republic, JPMorgan, Iveric Bio, SoFi, Norwegian Cruise, ON Semi, and MoreJPMorgan Chase is acquiring all the deposits and 'substantially all of the assets' of regional lender First Republic Bank. Iveric Bio is being bought by Japan's Astellas Pharma for $5.9 billion. |
ISEE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 26.18% |
| 3-year | 533.12% |
| 5-year | 2,753.57% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | 28.05% |
| 2021 | 141.97% |
| 2020 | -19.46% |
| 2019 | 615.00% |
Loading social stream, please wait...